Unisom Dosing Directions
For adults and children 12 years and older, take one tablet (25 mg doxylamine succinate for Unisom SleepTabs) 30 minutes before bedtime, once daily or as directed by a physician; do not use in children under 12 years of age 1.
Standard Dosing
The FDA-approved dosing for Unisom SleepTabs (doxylamine succinate 25 mg) is straightforward 1:
- Adults and children ≥12 years: 1 tablet (25 mg) taken 30 minutes before bedtime
- Frequency: Once daily or as directed by physician
- Children <12 years: Do not use
Important Clinical Context
While the FDA labeling provides clear dosing instructions, it's critical to understand that the American Academy of Sleep Medicine (AASM) 2017 guidelines explicitly recommend against using diphenhydramine (the other common Unisom formulation) for treating insomnia 2. The guideline does not specifically address doxylamine, but both are first-generation antihistamines with similar mechanisms and side-effect profiles.
Key Caveats
- Short-term use only: These products are intended for temporary, mild-to-moderate insomnia, not chronic sleep disorders
- Tolerance develops rapidly: The sedative effects diminish with continued use, typically within days to weeks
- Anticholinergic burden: First-generation antihistamines carry significant risks, particularly in older adults (cognitive impairment, falls, urinary retention, constipation)
- Next-day sedation: Despite the 30-minute pre-bedtime timing recommendation 1, doxylamine has a half-life of approximately 10 hours 3, which can cause morning grogginess
Pharmacokinetic Considerations
Research demonstrates that doxylamine 25 mg produces peak plasma concentrations around 2 hours post-dose with dose-proportional pharmacokinetics across the 12.5-25 mg range 3. The elimination half-life of approximately 10 hours 4 means residual effects may persist into the following day, though clinical trials have not consistently demonstrated significant residual impairment 5.
Clinical Pitfalls to Avoid
- Do not exceed recommended dose: Higher doses increase anticholinergic side effects without proportional benefit
- Avoid in elderly patients: Recent expert consensus strongly discourages diphenhydramine use due to adverse effects, particularly in older adults and children 6
- Not for chronic insomnia: If sleep problems persist beyond 2 weeks, refer for proper evaluation rather than continuing OTC antihistamines
- Drug interactions: Be aware of additive sedation with alcohol, benzodiazepines, opioids, and other CNS depressants
The evidence increasingly suggests that first-generation antihistamines like those in Unisom formulations represent suboptimal therapy for insomnia, with some experts calling for their removal from widespread availability 6. For persistent sleep issues, evidence-based alternatives include cognitive behavioral therapy for insomnia (CBT-I) or FDA-approved hypnotics with better safety profiles 2.